Entitlement Offer
Avecho (ASX:AVE) has today announced an Entitlement Offer to eligible shareholders to raise up to A$11 million.
Funds from this capital raise will fund Avecho’s pivotal randomised, placebo-controlled Phase III clinical trial, testing the Company’s TPM®-enhanced CBD soft-gel capsule for the management of insomnia.